Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00762151 · ClinicalTrials.gov registry record · Phase 1

A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste

A Phase 1 study of Dental Plaque, sponsored by Pfizer.

Completed
Registry status
Phase 1
Development phase
18
Enrollment target
1
Study location

NCT00762151 is a Phase 1 study of Dental Plaque that has completed, run by Pfizer. The registered enrollment target is 18 participants, below the 623-participant average among 10 other Dental Plaque trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00762151, a Phase 1 study of Dental Plaque, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 1
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The objective of this study was to evaluate the anti-plaque efficacy of the Anacor prototype dentrifice as compared to commercial control products following a single use of the dentrifice.

Conditions Studied

Interventions

  • OTHER Negative Control (Regular Toothpaste)
  • OTHER Positive Control (anti-plaque/anti-bacterial toothpaste)
  • DRUG Prototype (AN0128 Toothpaste)

Study Locations (1)

New Jersey

  • Concordia Research Laboratories - Cedar Knolls

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2007-11
Est. Completion 2008-01
Phase Phase 1

Sponsor

Pfizer

1,845 total trials

What the Registry Record Tells You About NCT00762151

The ClinicalTrials.gov registry entry for NCT00762151 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 623-participant average among 10 other Dental Plaque trials with a reported enrollment target (97% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Plaque appearing as the primary indexed condition, and to 3 interventions - of which Negative Control (Regular Toothpaste) is the first listed.

NCT00762151 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT00762151 about?

NCT00762151 is a clinical study titled "A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste". The objective of this study was to evaluate the anti-plaque efficacy of the Anacor prototype dentrifice as compared to commercial control products following a single use of the dentrifice.

What is the current status of trial NCT00762151?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2007-11. Estimated completion is 2008-01.

What conditions does trial NCT00762151 study?

This clinical trial studies the following conditions: Dental Plaque.

What interventions are being tested in trial NCT00762151?

The interventions under investigation include: Negative Control (Regular Toothpaste) (OTHER), Positive Control (anti-plaque/anti-bacterial toothpaste) (OTHER), Prototype (AN0128 Toothpaste) (DRUG).

Who is sponsoring clinical trial NCT00762151?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00762151 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Plaque

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.